RALLYBIO CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.85 USD | +1.09% |
|
+9.12% | -22.38% |
Chart calendar Rallybio Corporation
8a1d44f7cf70d7d69d073e9f98f7111.XpjN-KloUBmN1W4cRFpojwIlmcEU-KUG3zhxH910gBM.OvmAvoQwBWvsgSEtCBYDzmxAoJNmqcBUpVUQdZ8mw0obr_2b-Do9Xu6HVg~83c9be41dd3f19b8fc3514259c7ec783
Upcoming events on Rallybio Corporation
Past events on Rallybio Corporation
| 17/04/2024 19:00 | Academy of Managed Care Pharmacy Meeting - Poster Number: P1 |
| 12/03/2024 12:00 | Q4 2023 Earnings Release |
| 04/03/2024 14:10 | TD Cowen Health Care Conference - Panel |
| 10/01/2024 16:15 | J.P. Morgan Health Care Conference |
| 20/12/2023 13:30 | Business Update Call |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Abstract No: 1224 |
| 28/11/2023 12:30 | Evercore ISI HealthCONx Conference - Fireside Chat |
| 15/11/2023 20:00 | Stifel Healthcare Conference |
| 09/11/2023 13:00 | Q3 2023 Earnings Release |
| 10/10/2023 16:00 | JonesTrading Healthcare Summit |
| 27/09/2023 21:10 | Cantor Global Healthcare Conference |
| 12/09/2023 15:00 | H.C. Wainwright Global Investment Conference |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 07/09/2023 17:45 | Wells Fargo Healthcare Conference |
| 03/09/2023 19:30 | International Complement Workshop Congress - Abstract Number: 36 |
| 09/08/2023 16:00 | Wedbush PacGrow Healthcare Conference |
| 08/08/2023 13:00 | Q2 2023 Earnings Release |
| 24/06/2023 21:00 | International Society on Thrombosis and Haemostasis Congress - RLYB212 Phase 1b Proof-Of-Concept Stu |
| 24/06/2023 18:00 | International Society on Thrombosis and Haemostasis Congress - Abstract Presentation Number: OC 02.1 |
| 09/06/2023 14:00 | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -67,7 -70,2 3.59% | 0,00 -77,9 - | -68,0 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -45,6 -45,1 -1.21% | -67,9 -70,5 3.68% | -78,9 -77,8 -1.45% | -69,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -45,5 -45,1 -1% | -65,6 -66,7 1.68% | -72,5 -73,6 1.52% | -66,4 |
|
Net income Million USD | Released Forecast Spread | -26,4 | -47,0 -46,1 -2% | -66,7 -67,6 1.35% | -74,6 -73,9 -0.91% | -66,2 |
|
EPS USD | Released Forecast Spread | -9,95 | -1,84 -3,83 51.9% | -2,09 -2,38 12.16% | -1,84 -1,84 -0.02% | -1,60 |
| Announcement Date | 22/07/21 | 15/03/22 | 06/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -17,1 -20,0 14.74% | -20,0 -19,0 -5.5% | -19,3 -21,0 7.97% | -20,0 | -19,0 | -17,0 | -16,0 | -16,0 | ||||||
|
EBIT Million USD | Released Forecast Spread | -12,3 -11,8 -4.55% | -14,3 -13,5 -6.45% | -17,6 -18,5 4.96% | -18,9 -16,4 -14.88% | -17,1 -19,8 13.62% | -18,4 -19,1 3.93% | -20,1 -19,8 -1.34% | -19,4 -21,7 10.91% | -21,1 -20,0 -5.82% | -19,8 | -17,5 | -15,9 | -16,2 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,2 -11,8 -3.76% | -14,1 -12,9 -9.36% | -17,2 -18,3 5.77% | -18,2 -16,0 -13.98% | -16,0 -19,3 16.94% | -16,8 -18,0 7.17% | -18,4 -18,9 2.35% | -17,7 -21,0 15.76% | -19,6 -19,3 -1.59% | -18,6 | -17,3 | -15,7 | -16,4 | |
|
Net income Million USD | Released Forecast Spread | -12,4 -11,9 -4.15% | -14,5 -13,8 -5.06% | -17,6 -18,4 4.57% | -18,4 -16,7 -10.16% | -16,2 -19,4 16.51% | -17,3 -18,5 6.34% | -18,6 -19,3 3.46% | -18,4 -20,8 11.83% | -20,2 -19,2 -5.24% | -19,5 | -17,0 | -15,4 | -15,8 | |
|
EPS USD | Released Forecast Spread | -0,42 -0,41 -3.28% | -0,48 -0,47 -2.13% | -0,57 -0,61 6.56% | -0,60 -0,54 -11.11% | -0,46 -0,60 22.85% | -0,43 -0,50 14.57% | -0,46 -0,48 3.92% | -0,45 -0,51 12.38% | -0,50 -0,45 -11.02% | -0,47 | -0,42 | -0,38 | -0,36 | |
| Announcement Date | 15/03/22 | 10/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 09/05/23 | 08/08/23 | 09/11/23 | 12/03/24 | - | - | - | - | - |
More events
Past sector events for Rallybio Corporation
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RLYB Stock
- Calendar Rallybio Corporation
